Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Index by author

November 2024; Volume 44,Issue 11
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Abrial, CATHERINE

    1. Open Access
      Comparison of the Predictive and Prognostic Capacities of Neutrophil, Lymphocyte and Platelet Counts and Tumor-infiltrating Lymphocytes in Triple-negative Breast Cancer: Preliminary Results of the PERCEPTION Study
      ALEXIA GIRO, JUDITH PASSILDAS-JAHANMOHAN, MYRIAM KOSSAI, YANNICK BIDET, IOANA MOLNAR, MAUREEN BERNADACH, FREDERIQUE PENAULT-LLORCA, CATHERINE ABRIAL, XAVIER DURANDO and NINA RADOSEVIC-ROBIN
      Anticancer Research November 2024, 44 (11) 4983-4994; DOI: https://doi.org/10.21873/anticanres.17323
  2. Adams, JANA

    1. You have access
      Accuracy of Preoperative Magnet Resonance Imaging to Predict Pathologic T-Stage in Patients With Cervical Cancer
      CAROLINE LENZ, LARA GESEMANN, YUSSOR AL-BALDAWI, MICHAEL PÜSKEN, AMELIE WINGELS, PETER MALLMANN, CONSTANZE AMIR-KARIBIAN, JANICE K. JESCHKE, JANA ADAMS, BERND MORGENSTERN and FABINSHY THANGARAJAH
      Anticancer Research November 2024, 44 (11) 5081-5085; DOI: https://doi.org/10.21873/anticanres.17332
  3. Aires, INÊS

    1. Open Access
      Interplay Between Western Diet and Mammary Cancer: Data from a Chemically-induced Model in Wistar Rats
      JESSICA SILVA, TIAGO AZEVEDO, INÊS AIRES, FRANCISCO PEIXOTO, MARIA J. NEUPARTH, FELISBINA L. QUEIROGA, FERNANDA SEIXAS, RITA FERREIRA, ANA I. FAUSTINO-ROCHA, JOSÉ ALBERTO DUARTE and PAULA A. OLIVEIRA
      Anticancer Research November 2024, 44 (11) 4843-4856; DOI: https://doi.org/10.21873/anticanres.17310
  4. Akbarpour, FERRE

    1. Open Access
      Investigation of the Efficacy of Nowarta110 in the Treatment of HPV-16 and HPV-18 Oncogenically-transformed Human Cells and Cancer-implanted Animal Models
      JON SIN, MATEI KIOSEA, KHOSROW MAHDAVI, FERRE AKBARPOUR, JOLIE NGUYEN, BO HAN and BA X. HOANG
      Anticancer Research November 2024, 44 (11) 4723-4728; DOI: https://doi.org/10.21873/anticanres.17298
  5. Akiyama, YASUTO

    1. Open Access
      A Gene Expression Signature that Predicts Gastric Cancer Sensitivity to PARP Inhibitor Therapy
      KEIICHI FUJIYA, MASAKUNI SERIZAWA, KEIICHI OHSHIMA, RINA UMEHARA, YUKO WATANABE, TAKESHI NAGASHIMA, ETSURO BANDO, KENICHI URAKAMI, YASUTO AKIYAMA, YASUHIRO TSUBOSA, TAKASHI SUGINO, KEN YAMAGUCHI and MASANORI TERASHIMA
      Anticancer Research November 2024, 44 (11) 4779-4788; DOI: https://doi.org/10.21873/anticanres.17304
  6. Al-baldawi, YUSSOR

    1. You have access
      Accuracy of Preoperative Magnet Resonance Imaging to Predict Pathologic T-Stage in Patients With Cervical Cancer
      CAROLINE LENZ, LARA GESEMANN, YUSSOR AL-BALDAWI, MICHAEL PÜSKEN, AMELIE WINGELS, PETER MALLMANN, CONSTANZE AMIR-KARIBIAN, JANICE K. JESCHKE, JANA ADAMS, BERND MORGENSTERN and FABINSHY THANGARAJAH
      Anticancer Research November 2024, 44 (11) 5081-5085; DOI: https://doi.org/10.21873/anticanres.17332
  7. Amir-karibian, CONSTANZE

    1. You have access
      Accuracy of Preoperative Magnet Resonance Imaging to Predict Pathologic T-Stage in Patients With Cervical Cancer
      CAROLINE LENZ, LARA GESEMANN, YUSSOR AL-BALDAWI, MICHAEL PÜSKEN, AMELIE WINGELS, PETER MALLMANN, CONSTANZE AMIR-KARIBIAN, JANICE K. JESCHKE, JANA ADAMS, BERND MORGENSTERN and FABINSHY THANGARAJAH
      Anticancer Research November 2024, 44 (11) 5081-5085; DOI: https://doi.org/10.21873/anticanres.17332
  8. An, JIYEON

    1. You have access
      Over-expression of Transmembrane Protein 158 Predicts Aggressive Tumor Behavior and Poor Prognosis in Lung Cancer
      MIYEON JEON, SEONGKYEONG YOO, SOOHYUN PARK, YUNSUP CHOI, JIYEON AN, YOO RIM NOH and ILJIN KIM
      Anticancer Research November 2024, 44 (11) 4885-4893; DOI: https://doi.org/10.21873/anticanres.17314
  9. Aoyama, TORU

    1. Open Access
      Biomarker Study for Selecting Neoadjuvant Chemotherapy Regimens Based on Prognostic Prediction Using Gastric Cancer Biopsy Specimens from a Phase II Randomized Controlled Trial
      TAKASHI OSHIMA, TAKAKI YOSHIKAWA, YOHEI MIYAGI, SATOSHI MORITA, MICHIO YAMAMOTO, KAZUAKI TANABE, KAZUHIRO NISHIKAWA, YUICHI ITO, TAKANORI MATSUI, YUTAKA KIMURA, TORU AOYAMA, TAKASHI OGATA, HARUHIKO CHO, AKIRA TSUBURAYA and JUNICHI SAKAMOTO
      Anticancer Research November 2024, 44 (11) 4951-4960; DOI: https://doi.org/10.21873/anticanres.17320
    2. Open Access
      The Clinical Impact of the Systemic Immune-inflammation Index in Esophageal Cancer Patients Receiving Curative Treatment
      RYUKI ESASHI, TORU AOYAMA, YUKIO MAEZAWA, ITARU HASHIMOTO, SOSUKE YAMAMOTO, MAMORU UCHIYAMA, KOJI NUMATA, SHINNOSUKE KAWAHARA, KEISUKE KAZAMA, AYAKO TAMAGAWA, AYA SAITO and NORIO YUKAWA
      Anticancer Research November 2024, 44 (11) 5035-5041; DOI: https://doi.org/10.21873/anticanres.17327
  10. Ashihara, EISHI

    1. Open Access
      Compound #41 Targets Acute Myelogenous Leukemia by Inhibiting the Wnt/β-catenin Signaling Pathway
      YUKI HADATE, YASUNAO HATTORI, YUKI TODA, SHIGEKUNI HOSOGI, SEIJI OKADA, YOSHIHIRO HAYASHI and EISHI ASHIHARA
      Anticancer Research November 2024, 44 (11) 4789-4799; DOI: https://doi.org/10.21873/anticanres.17305
« Previous (Pages : 1 2 3 4 5 6 ... 42) Next »
Back to top
PreviousNext

In this issue

Anticancer Research: 44 (11)
Anticancer Research
Vol. 44, Issue 11
November 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • Immunoliposomes for Neuroblastoma: Review of the Past Experience and Design of a Novel Nanoparticle
  • Potential Transcriptomic Biomarkers for Predicting Platinum-based Chemotherapy Resistance in Patients With High-grade Serous Ovarian Cancer
  • Biomarker Study for Selecting Neoadjuvant Chemotherapy Regimens Based on Prognostic Prediction Using Gastric Cancer Biopsy Specimens from a Phase II Randomized Controlled Trial
  • Understanding the Genomic Landscape of Glioblastoma: Opportunities for Targeted Therapies
  • Chemokine Profile Is Different in Normal Testis Compared to Seminoma – Especially in Tumor Infiltrating Lymphocytes
Sign up for alerts
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire